Serotonin-transporter mediated efflux: A pharmacological analysis of amphetamines and non-amphetamines

被引:76
作者
Hilber, B [1 ]
Scholze, P [1 ]
Dorostkar, MM [1 ]
Sandtner, W [1 ]
Holy, M [1 ]
Boehm, S [1 ]
Singer, EA [1 ]
Sitte, HH [1 ]
机构
[1] Univ Vienna, Inst Pharmacol, A-1090 Vienna, Austria
基金
奥地利科学基金会;
关键词
carrier-mediated efflux; amphetamine; serotonin; facilitated exchange diffusion model; channel properties;
D O I
10.1016/j.neuropharm.2005.08.008
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The physiological function of neurotransmitter transporter proteins like the serotonin transporter (SERT) is reuptake of neurotransmitter that terminates synaptic serotoninergic transmission. SERT can operate in reverse direction and be induced by SERT substrates including 5-HT, tyramine and the positively charged methyl-phenylpyridinium (MPP+), as well as the amphetamine derivatives para-chloroamphetamine (pCA) and methylene-dioxy-methamphetamine (MDMA). These substrates also induce inwardly directed sodium currents that are predominantly carried by sodium ions. Efflux via SERT depends on this sodium flux that is believed to be a prerequisite for outward transport. However, in recent studies, it has been suggested that substrates may be distinct in their properties to induce efflux. Therefore, the aim of the present study was a pharmacological characterization of different SERT substrates in uptake experiments, their abilities to induce transporter-mediated efflux and currents. In conclusion, the rank order of affinities in uptake and electrophysiological experiments correlate well, while the potencies of the amphetamine derivatives for the induction of efflux are clearly higher than those of the other substrates. These discrepancies can be only explained by mechanisms that can be induced by amphetamines. Therefore, based on our pharmacological observations, we conclude that amphetamines distinctly differ from non-amphetamine SERT substrates. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:811 / 819
页数:9
相关论文
共 39 条
[1]   Flux coupling in the human serotonin transporter [J].
Adams, SV ;
DeFelice, LJ .
BIOPHYSICAL JOURNAL, 2002, 83 (06) :3268-3282
[2]   NONVESICULAR RELEASE OF NEUROTRANSMITTER [J].
ATTWELL, D ;
BARBOUR, B ;
SZATKOWSKI, M .
NEURON, 1993, 11 (03) :401-407
[3]  
Barker Eric L., 1995, P321
[4]  
BONISCH H, 1989, HDB EXPT PHARM CATEC, P247
[5]   The Transporter Classification (TC) system, 2002 [J].
Busch, W ;
Saier, MH .
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2002, 37 (05) :287-337
[6]   HIGH-EFFICIENCY TRANSFORMATION OF MAMMALIAN-CELLS BY PLASMID DNA [J].
CHEN, C ;
OKAYAMA, H .
MOLECULAR AND CELLULAR BIOLOGY, 1987, 7 (08) :2745-2752
[7]   Carrier-mediated serotonin release induced by d-fenfluramine: Studies with human neuroblastoma cells transfected with a rat serotonin transporter [J].
Cinquanta, M ;
Ratovitski, T ;
Crespi, D ;
Gobbi, M ;
Mennini, T ;
Simantov, R .
NEUROPHARMACOLOGY, 1997, 36 (06) :803-809
[8]   Carrier-dependent and Ca2+-dependent 5-HT and dopamine release induced by (+)-amphetamine, 3,4-methylendioxymethamphetamine, p-chloroamphetamine and(+)-fenfluramine [J].
Crespi, D ;
Mennini, T ;
Gobbi, M .
BRITISH JOURNAL OF PHARMACOLOGY, 1997, 121 (08) :1735-1743
[9]  
FISCHER JF, 1979, J PHARMACOL EXP THER, V208, P203
[10]   Norepinephrine transporters have channel modes of conduction [J].
Galli, A ;
Blakely, RD ;
DeFelice, LJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (16) :8671-8676